This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Doxorubicin and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (1)
Death (1)
Reports by Reaction Type
Gastrointestinal Haemorrhage (1),
Disseminated Intravascular Coagulation (1),
Metabolic Acidosis (1),
Hyperphosphataemia (1),
Hypophosphataemia (1),
Tumour Lysis Syndrome (1)
Possible Doxorubicin side effects in 51 year old male
Reported by a physician from Japan on 2012-08-20
Patient: 51 year old male
Reactions: Hypophosphataemia, Metabolic Acidosis, Tumour Lysis Syndrome, Gastrointestinal Haemorrhage, Hyperphosphataemia, Disseminated Intravascular Coagulation
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1200 mg, unk
Indication: Lymphoma
Vincristine
Dosage: 2 mg, unk
Indication: Lymphoma
Methylprednisolone
Dosage: 60 mg/day
Allopurinol
Dosage: unk
Methylprednisolone
Dosage: 250 mg/day
Indication: Lymphoma
Doxorubicin
Dosage: 80 mg, unk
Indication: Lymphoma
Sodium Bicarbonate
Indication: Metabolic Acidosis
|